Key result
Thrombolytic therapy can cause diffuse intra-alveolar haemorrhage, a rare complication presenting with respiratory distress, haemoptysis, and unexplained haemoglobin drop.
Diffuse intra-alveolar haemorrhage is a rare but important complication of thrombolytic therapy in acute myocardial infarction that should be considered in patients presenting with respiratory distress and haemoptysis.
Alerts clinicians to alveolar haemorrhage in post-thrombolysis respiratory distress with haemoglobin drop; single case leaves incidence and risk factors undetermined.
Diffuse intra-alveolar haemorrhage is a rare complication of thrombolytic therapy (TT). We report a patient who developed haemoptysis due to pulmonary haemorrhage. This diagnosis should be considered in any patients with respiratory distress, diffuse pulmonary infiltrates, and haemoptysis and otherwise unexplained decrease in haemoglobin concentration after thrombolytic therapy.
No takes yet. Share an insight, caveat, or question.
Baran et al. (2004) studied this question. Thrombolytic therapy can cause diffuse intra-alveolar haemorrhage, a rare complication presenting with respiratory distress, haemoptysis, and unexplained haemoglobin drop.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: